Linda Baddour, Gary Hendrickson

Sep 06, 2018

Waters announced today that has appointed Linda Baddour and Gary Hendrickson as directors of the firm.

Baddour has served as executive VP and CFO at PRA Health Sciences since 2007. Prior to PRA, she served as CFO at Pharmaceutical Product Development. Beforhand, she also served as treasurer and chief accounting officer at the firm.

Prior to Waters, Hendrickson served as Chairman of Valspar between 2012 and 2017, and CEO since 2011. Prior to CEO, Hendrickson acted as COO, president of several business units, and corporate VP and President of the firm's Asia Pacific branch.

Linda Baddour, Gary Hendrickson

Sickle Cell Trait Carriers Run Higher Risk of Blood Clots Regardless of Ancestry

Inflammatix Raises $57M in Series E Financing

Pacific Biosciences Helps Launch Sequencing-Based Fertility Research Consortium in Asia

Ovarian Aging Study Finds Rare Variant Contributors With Ties to DNA Damage Response, Cancer

Agena Bioscience Expands Into South America With Distribution Deals in Argentina, Brazil